Tuesday, Jan 18, 2022 | Last Update : 10:34 PM IST

drug controller general of india (dcgi)

Cadila Healthcare gets DCGI nod to conduct phase 3 trials for two-dose COVID vaccine

The company has got the permission for conduct of phase III trials for two-dose Covid vaccine, Cadila Healthcare said in a regulatory filing

05 Oct 2021 5:22 PM

LifeCell gets DCGI nod for clinical trial of cell therapy to treat COVID patients

The company has set up a manufacturing facility at its Chennai campus that will further bolster its biologics manufacturing capabilities

16 Sep 2021 3:15 PM

Mylan Pharma to launch remdesivir in India at Rs 4,800 per 100 mg vial

The drug will be launched under the brand name Desrem in India and will be available to patients later this month

07 Jul 2020 1:48 PM

Hetero gets DCGI nod to launch Remdesivir for COVID-19 treatment

The drug will be available in 100 mg vial which will be administered intravenously in a hospital under healthcare practitioner supervision

21 Jun 2020 2:45 PM

India's Glenmark to conduct trials for potential Covid19 drug

Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%

30 Apr 2020 12:28 PM

ADVERTISEMENT

India will import drugs with less than 60 pc shelf life, condition apply

Health ministry has instructed to take various steps to ensure availability of a sufficient quantity of drugs in the domestic retail market

19 Apr 2020 11:20 AM

ADVERTISEMENT
ADVERTISEMENT